Jesper Vraamark Elberling

Jesper Vraamark Elberling serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, specializing in Dermatovenerology. Based at Blegdamsvej 3, Copenhagen, he maintains active clinical and research roles within the Capital Region of Denmark (Region Hovedstaden), evidenced by his institutional email domain.

His research focuses on inflammatory skin disorders with emphasis on atopic dermatitis pathophysiology, prurigo nodularis epidemiology, and allergic contact mechanisms. Key investigations include biologic therapies (lebrikizumab), JAK inhibitor safety profiles, and dermatological manifestations of systemic conditions like asthma comorbidity. His work bridges clinical dermatology with immunological mechanisms of itch and sensitization.

Analysis of his 2024-2025 publications reveals three dominant trends: (1) therapeutic innovation in moderate-severe atopic dermatitis through Phase III trials, (2) epidemiological methodology using novel data sources like web search analytics for disease burden assessment, and (3) rare clinical presentations documented through case reports on conditions like Morbihan disease and cosmetic-induced dermatitis. His research consistently involves multinational European collaborations.

No scientific awards were documented in the available materials.